foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Biotech and medtech seed funding: what lies ahead?

The 4th annual Biotech and Money/Medtech and Money World Congress will offe...

Read More

Top five biotech developments in the last 10 years...

Biotech is one of the fastest growing industry sectors and, with the pace o...

Read More

Self-perpetuating myths and attitudes in the Biote...

There are several self-perpetuating myths and attitudes in the Biotech sect...

Read More

Top 4 Tips you need to prepare for Biotech IPO

Biotech companies have fared well recently in the IPO market in both the US...

Read More

Further additions to the lineup of presenters at t...

We’re delighted to announce further additions to the lineup of presenters a...

Read More

The Brexit Referendum Result

John Rountree, Managing Partner of Novasecta, a specialist pharmaceutical m...

Read More

How to access family office capital as a life scie...

Family Offices are, by design, a much more private group than other other i...

Read More

Issue 10, 2016 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

Biotechs and the City Summer, 21st June

Leaving the EU would have enormous implications for biotech and life scienc...

Read More

Lord Darzi: Leaving the EU would be ‘disastrous’ f...

In this article, Professor Lord Darzi of Denham, director of the Institute ...

Read More

Brexit: implications for the life sciences sector

If the UK votes to exit the European Union (Brexit) following the referendu...

Read More

Brexit and the Implications for the Life Sciences ...

With the UK's referendum on whether Britain should leave the European Union...

Read More

Add Your Response